Association of matrix metalloproteinases 1, 7, and 9 gene polymorphisms with genetic susceptibility to colorectal carcinoma in a Han Chinese population

DNA and Cell Biology

Volumn 29, Issue 11, 2010, Pages 657-661

  Fang, Wen Liang ^a,b   Liang, Wei Bo ^a   He, Huan ^a   Zhu, Yi ^a   Li, Shi Liu ^a   Gao, Lin Bo ^a   Zhang, Lin ^a  

^a SICHUAN UNIVERSITY   (China)

^b ANHUI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GELATINASE B; INTERSTITIAL COLLAGENASE; MATRILYSIN;

ADULT; ARTICLE; CANCER RISK; CHINESE; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA SEQUENCE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC SUSCEPTIBILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; SINGLE NUCLEOTIDE POLYMORPHISM;

ASIAN CONTINENTAL ANCESTRY GROUP; COLORECTAL NEOPLASMS; ETHNIC GROUPS; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 7; MATRIX METALLOPROTEINASE 9; MATRIX METALLOPROTEINASES; MIDDLE AGED; POLYMORPHISM, GENETIC;

EID: 77958596170     PISSN: 10445498     EISSN: None     Source Type: Journal    
DOI: 10.1089/dna.2010.1017     Document Type: Article

References (31)

1. Bendrik, C., et al. (2010). Increased endostatin generation and decreased angiogenesis via MMP-9 by tamoxifen in hormone dependent ovarian cancer. Cancer Lett 292, 32-40.
2. Center, M.M., et al. (2009). Worldwide variations in colorectal cancer. CA Cancer J Clin 59, 366-378.
3. Daniel, P., et al. (2007). Transforming growth factor beta 1 and metalloproteinase-9 overexpression in colorectal cancer (CC) and adenoma. Int J Colorectal Dis 22, 1165-1172.
4. de Lima, J.M., et al. (2009). E-cadherin and metalloproteinase-1 and -7 polymorphisms in colorectal cancer. Int J Biol Markers 24, 99-106.
5. Decock, J., et al. (2008). Genetic polymorphisms of matrix me-talloproteinases in lung, breast and colorectal cancer. Clin Genet 73, 197-211.
6. Elander, N., et al. (2006). Matrix metalloproteinase (MMP) -1, -2, -3 and -9 promoter polymorphisms in colorectal cancer. Anticancer Res 26, 791-795.
7. Fang, Y.J., et al. (2009). Elevated expressions of MMP7, TROP2, and survivin are associated with survival, disease recurrence, and liver metastasis of colon cancer. Int J Colorectal Dis 24, 875-884.
8. Ghilardi, G., et al. (2003). Colorectal carcinoma susceptibility and metastases are associated with matrix metalloproteinase-7 promoter polymorphisms. Clin Chem 49, 1940-1942.
9. Gryfe, R. (2009). Overview of colorectal cancer genetics. Surg Oncol Clin N Am 18, 573-583.
10. Herszenyi, L., et al. (2007). Alterations of glutathione S-transferase and matrix metalloproteinase-9 expressions are early events in esophageal carcinogenesis. World J Gastro-enterol 13, 676-682.
11. Hettiaratchi, A., et al. (2007). The collagenase-1 (MMP-1) gene promoter polymorphism -607/2G is associated with favourable prognosis in patients with colorectal cancer. Br J Cancer 96, 783-792.
12. Hilska, M., et al. (2007). Prognostic significance of matrix metalloproteinases-1, -2, -7 and -13 and tissue inhibitors of metalloproteinases-1, -2, -3 and -4 in colorectal cancer. Int J Cancer 121, 714-723.
13. Hu, Z., et al. (2005). Functional polymorphisms of matrix metalloproteinase-9 are associated with risk of occurrence and metastasis of lung cancer. Clin Cancer Res 11, 5433-5439.
14. Jormsjo, S., et al. (2001). Allele-specific regulation of matrix metalloproteinase-7 promoter activity is associated with coronary artery luminal dimensions among hypercholes-terolemic patients. Arterioscler Thromb Vasc Biol 21, 1834-1839.
15. Knox, P.G., et al. (1996). In vitro production of stable Epstein-Barr virus-positive epithelial cell clones which resemble the virus: cell interaction observed in nasopharyngeal carcinoma. Virology 215, 40-50.
16. Kouhkan, F., et al. (2008). The influence of interstitial collagenase-1 genotype polymorphism on colorectal cancer risk in Iranian population. Cancer Invest 26, 836-842.
17. Luukkaa, H., et al. (2010). Matrix metalloproteinase (MMP)-7 in salivary gland cancer. Acta Oncol 49, 85-90.
18. Parkin, D.M., et al. (2005). Global cancer statistics, 2002. CA Cancer J Clin 55, 74-108.
19. Pellikainen, J.M., et al. (2004). Expression of matrix metallopro-teinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis. Clin Cancer Res 10, 7621-7628.
20. Roy, R., et al. (2009). Matrix metalloproteinases as novel bio-markers and potential therapeutic targets in human cancer. J Clin Oncol 27, 5287-5297.
21. Rutter, J.L., et al. (1998). A single nucleotide polymorphism in the matrix metalloproteinase-1 promoter creates an Ets binding site and augments transcription. Cancer Res 58, 5321-5325.
22. Somerville, R.P., et al. (2003). Matrix metalloproteinases: old dogs with new tricks. Genome Biol 4, 216.
23. St Jean, P.L., et al. (1995). Characterization of a dinucleotide repeat in the 92kDa type IV collagenase gene (CLG4B), localization of CLG4B to chromosome 20 and the role of CLG4B in aortic aneurysmal disease. Ann Hum Genet 59, 17-24.
24. Sun, W.H., et al. (2005). Expression of cyclooxygenase-2 and matrix metalloproteinase-9 in gastric carcinoma and its correlation with angiogenesis. Jpn J Clin Oncol 35, 707-713.
25. Wei, Y.S., et al. (2007). Interleukin-10 gene promoter polymorphisms and the risk of nasopharyngeal carcinoma. Tissue Antigens 70, 12-17.
26. Wilson, C.L., and Matrisian, L.M. (1996). Matrilysin: an epithelial matrix metalloproteinase with potentially novel functions. Int J Biochem Cell Biol 28, 123-136.
27. Woo, M., et al. (2007). Clinical implications of matrix metalloproteinase-1, -3, -7, -9, -12, and plasminogen activator inhibitor-1 gene polymorphisms in colorectal cancer. J Gastroenterol Hepatol 22, 1064-1070.
28. Wu, J., et al. (2008). Association of matrix metalloproteinases-9 gene polymorphisms with genetic susceptibility to esophageal squamous cell carcinoma. DNA Cell Biol 27, 553-557.
29. Xing, L.L., et al. (2007). Matrix metalloproteinase-9-1562C > T polymorphism may increase the risk of lymphatic metastasis of colorectal cancer. World J Gastroenterol 13, 4626-4629.
30. Xu, E., et al. (2006). No association between the polymorphisms in matrix metalloproteinase-1 and matrix metalloproteinase-3 promoter regions and colorectal cancer in Chinese. Dis Colon Rectum 49, 1439-1444.
31. Ye, S., et al. (2001). Invasiveness of cutaneous malignant melanoma is influenced by matrix metalloproteinase 1 gene polymorphism. Cancer Res 61, 1296-1298.